{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:25:56Z","timestamp":1787664356269,"version":"build-2736575974"},"reference-count":64,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Placental dysfunction underlies major obstetric complications, including preeclampsia, fetal growth restriction, preterm birth, and stillbirth. While early identification of pregnancies at high risk of complications enables preventive interventions, current screening methods based on traditional risk factors have limited accuracy.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study aims to develop robust prediction models for placental dysfunction\u2013related pregnancy disorders across 3 gestational windows and to determine the optimal delivery time by integrating maternal characteristics, biophysical measurements, and maternal circulating biomarkers.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n The Placental Health Study is a prospective cohort study conducted at the Maternal Fetal Medicine Unit at Gold Coast University Hospital, Australia. Singleton pregnancies are enrolled at 11 to 13 weeks, 26 to 28 weeks, and 35 to 36 weeks of gestation and are followed until delivery. Exclusion criteria are multiple pregnancies, major fetal anomalies, maternal age below 18 years, and inability to provide informed consent. Clinical data, standardized ultrasound and Doppler measurements, hemodynamic parameters, and biospecimens (serum, plasma, whole blood RNA, and urine) are collected at each visit. Three gestational age-specific datasets (11\u201013 weeks, 26\u201028 weeks, and 35\u201036 weeks) will be constructed for model development. Prediction models will be developed using multivariable logistic regression. Competing risks (Fine and Gray) models will be used as sensitivity analyses for outcomes related to gestational age at delivery. Bayesian updating will be applied to refine existing Fetal Medicine Foundation risk estimates using additional biomarkers or variables collected later in pregnancy. Developed models will undergo internal validation via 5-fold cross-validation, with performance assessed through model discrimination, calibration, and comparison against existing approaches. Collected biospecimens will also be analyzed for angiogenic markers and exploratory omics studies.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Recruitment occurred from June 2022 to February 2026, enrolling 1267 participants. As of submission, 1072 (84.6%) participants have completed their pregnancies, 144 (11.4%) participants remain active in follow-up, and 51 (4%) were withdrawn or had missing or duplicated data. Clinical data have undergone preliminary cleaning and descriptive analysis. Biospecimens are being processed for biomarker quantification and exploratory molecular analyses. Two to three publications are anticipated in late 2026 or early 2027.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n This cohort establishes a comprehensive database and biospecimen repository to advance prediction of placental dysfunction\u2013related complications. Three-stage recruitment integrated into routine clinical care enhances feasibility and translation potential, enabling dynamic risk assessment and investigation of temporal biomarker changes. Although the single-center design may limit generalizability, warranting future external validation, the interdisciplinary research team brings diverse expertise that strengthens study depth and scope.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/95231","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:45:09Z","timestamp":1781793909000},"page":"e95231-e95231","source":"Crossref","is-referenced-by-count":0,"title":["Prediction of Pregnancy Complications Related to Placental Dysfunction: Protocol for a Prospective Cohort Study (Placental Health Study)"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5501-1378","authenticated-orcid":false,"given":"Luhao","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5798-5264","authenticated-orcid":false,"given":"Olivia","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6599-6692","authenticated-orcid":false,"given":"Hasini","family":"Rathnayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1603-4291","authenticated-orcid":false,"given":"Cristiane","family":"de Freitas Paganoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8095-9873","authenticated-orcid":false,"given":"Conrado S\u00e1vio","family":"Ragazini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4209-2136","authenticated-orcid":false,"given":"Elsa Suk Fan","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4821-7038","authenticated-orcid":false,"given":"Sally","family":"Mahler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8191-1778","authenticated-orcid":false,"given":"Carman Wing Sze","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2263-3592","authenticated-orcid":false,"given":"Daniel Lorber","family":"Rolnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9829-6772","authenticated-orcid":false,"given":"Anthony","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4512-6443","authenticated-orcid":false,"given":"David","family":"Ellwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0832-4811","authenticated-orcid":false,"given":"Sailesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0765-7780","authenticated-orcid":false,"given":"Fabricio","family":"Da Silva Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"R1","unstructured":"Wardinger JE Vadakekut ES . Placental insufficiency. In: StatPearls [Internet]. StatPearls Publishing; 2025. URL: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK563171\/ [Accessed 13-08-2026]"},{"issue":"Suppl 3","key":"R2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/1471-0528.17613","article-title":"The great obstetrical syndromes and the placenta","volume":"130","author":"Hoffman","journal-title":"BJOG"},{"issue":"1","key":"R3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","article-title":"Pre-eclampsia","volume":"9","author":"Dimitriadis","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"R4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ogc.2021.02.002","article-title":"Abnormal fetal growth: small for gestational age, fetal growth restriction, large for gestational age: definitions and epidemiology","volume":"48","author":"Damhuis","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"6","key":"R5","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","journal-title":"Lancet Glob Health"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2024.101054","article-title":"The influence of birthweight on mortality and severe neonatal morbidity in late preterm and term infants: an Australian cohort study","volume":"45","author":"Triggs","journal-title":"Lancet Reg Health West Pac"},{"issue":"6","key":"R7","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1161\/HYPERTENSIONAHA.117.09499","article-title":"Estimating the cost of preeclampsia in the healthcare system: cross-sectional study using data from SCOPE study (screening for pregnancy end points)","volume":"70","author":"Fox","journal-title":"Hypertension"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2020.06.007","article-title":"The cost of Hypertensive Disorders of Pregnancy to the Australian healthcare system","volume":"21","author":"Fox","journal-title":"Pregnancy Hypertens"},{"issue":"1","key":"R9","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-017-2155-x","article-title":"Prenatal and post-natal cost of small for gestational age infants: a national study","volume":"17","author":"Marzouk","journal-title":"BMC Health Serv Res"},{"issue":"9","key":"R10","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/1471-0528.16683","article-title":"Pre-eclampsia and long-term health outcomes for mother and infant: an umbrella review","volume":"128","author":"Pittara","journal-title":"BJOG"},{"issue":"20","key":"R11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11206048","article-title":"Preeclampsia and fetal growth restriction as risk factors of future maternal cardiovascular disease-a review","volume":"11","author":"S\u0142awek-Szmyt","journal-title":"J Clin Med"},{"issue":"1","key":"R12","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-021-04152-2","article-title":"Fetal growth restriction as the initial finding of preeclampsia is a clinical predictor of maternal and neonatal prognoses: a single-center retrospective study","volume":"21","author":"Takahashi","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"R13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.siny.2017.11.004","article-title":"Screening for fetal growth restriction and placental insufficiency","volume":"23","author":"Audette","journal-title":"Semin Fetal Neonatal Med"},{"issue":"2","key":"R14","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1097\/AOG.0000000000003070","article-title":"ACOG Practice Bulletin No. 204: Fetal Growth Restriction","volume":"133","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Obstetrics and the Society for Maternal-Fetal Medicine.","journal-title":"Obstet Gynecol"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2019.07.004","article-title":"The two-stage placental model of preeclampsia: an update","volume":"134-135","author":"Staff","journal-title":"J Reprod Immunol"},{"issue":"2S","key":"R16","doi-asserted-by":"publisher","first-page":"S745","DOI":"10.1016\/j.ajog.2017.11.577","article-title":"Pathophysiology of placental-derived fetal growth restriction","volume":"218","author":"Burton","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"R17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/uog.19039","article-title":"Comparison of diagnostic accuracy of early screening for pre\u2010eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE","volume":"51","author":"Tan","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2024.03.001","article-title":"A longitudinal and cross-sectional study of placental circulation between normal and placental insufficiency pregnancies","volume":"149","author":"Chen","journal-title":"Placenta"},{"issue":"2","key":"R19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.11152\/mu-4355","article-title":"Utility of uterine artery Doppler ultrasound imaging in predicting preeclampsia during pregnancy: a meta-analysis","volume":"26","author":"Cao","journal-title":"Med Ultrason"},{"issue":"2","key":"R20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/uog.26032","article-title":"Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction","volume":"61","author":"Stepan","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2017.01.119","article-title":"Review: placental derived biomarkers of pregnancy disorders","volume":"54","author":"Cuffe","journal-title":"Placenta"},{"issue":"2","key":"R22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/uog.19112","article-title":"Screening for pre\u2010eclampsia by maternal factors and biomarkers at 11\u201313\u2009weeks\u2019 gestation","volume":"52","author":"Tan","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"R23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/uog.19077","article-title":"Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE","volume":"52","author":"Tan","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"7","key":"R24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","journal-title":"N Engl J Med"},{"issue":"6","key":"R25","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1097\/01.AOG.0000264552.85436.a1","article-title":"Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia","volume":"109","author":"Wikstr\u00f6m","journal-title":"Obstet Gynecol"},{"issue":"5","key":"R26","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/1471-0528.17370","article-title":"Preterm and term pre-eclampsia: relative burdens of maternal and perinatal complications","volume":"130","author":"von Dadelszen","journal-title":"BJOG"},{"issue":"5","key":"R27","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1161\/HYPERTENSIONAHA.122.20565","article-title":"Preeclampsia prevention by timed birth at term","volume":"80","author":"Magee","journal-title":"Hypertension"},{"issue":"2","key":"R28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1161\/HYPERTENSIONAHA.118.11092","article-title":"Association between prepregnancy cardiovascular function and subsequent preeclampsia or fetal growth restriction","volume":"72","author":"Foo","journal-title":"Hypertension"},{"issue":"5","key":"R29","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/uog.24851","article-title":"Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia","volume":"59","author":"Reddy","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","journal-title":"J Biomed Inform"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","journal-title":"Pregnancy Hypertens"},{"issue":"3","key":"R32","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: a Delphi procedure","volume":"48","author":"Gordijn","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R33","unstructured":"Hypertension in pregnancy: diagnosis and management. National Institute for Health and Care Excellence. 2019. URL: https:\/\/www.nice.org.uk\/guidance\/ng133 [Accessed 13-08-2026]"},{"issue":"6","key":"R34","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222","volume":"135","journal-title":"Obstet Gynecol"},{"issue":"6","key":"R35","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/uog.20272","article-title":"ISUOG practice guidelines: ultrasound assessment of fetal biometry and growth","volume":"53","author":"Salomon","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"R36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/uog.20105","article-title":"ISUOG practice guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia","volume":"53","author":"Sotiriadis","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"R37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/uog.17209","article-title":"Ophthalmic artery Doppler analysis: a window into the cerebrovasculature of women with pre-eclampsia","volume":"49","author":"Kane","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2017.08.002","article-title":"Protocol for measurement of mean arterial pressure at 10-40 weeks\u2019 gestation","volume":"10","author":"Roberts","journal-title":"Pregnancy Hypertens"},{"key":"R39","unstructured":"PAXgene blood RNA tubes (IVD). QIAGEN. URL: https:\/\/www.qiagen.com\/us\/products\/discovery-and-translational-research\/sample-collection-stabilization\/rna\/paxgene-blood-rna-tubes [Accessed 13-08-2026]"},{"issue":"2","key":"R40","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000357842","article-title":"Maternal serum placental growth factor (PlGF) isoforms 1 and 2 at 11-13 weeks\u2019 gestation in normal and pathological pregnancies","volume":"36","author":"Nucci","journal-title":"Fetal Diagn Ther"},{"issue":"1","key":"R41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","journal-title":"N Engl J Med"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m441","article-title":"Calculating the sample size required for developing a clinical prediction model","volume":"368","author":"Riley","journal-title":"BMJ"},{"issue":"2S","key":"R43","doi-asserted-by":"publisher","first-page":"S1071","DOI":"10.1016\/j.ajog.2020.07.020","article-title":"First trimester preeclampsia screening and prediction","volume":"226","author":"Chaemsaithong","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"R44","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1080\/14767058.2017.1378332","article-title":"Validation of Fetal Medicine Foundation algorithm for prediction of pre-eclampsia in the first trimester in an unselected Brazilian population","volume":"32","author":"Lobo","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"R45","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000477934","article-title":"First-trimester combined multimarker prospective study for the detection of pregnancies at a high risk of developing preeclampsia using the Fetal Medicine Foundation-algorithm","volume":"43","author":"Guizani","journal-title":"Fetal Diagn Ther"},{"issue":"6","key":"R46","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/ajo.12126","article-title":"Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy","volume":"53","author":"Park","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"3","key":"R47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/uog.13435","article-title":"First-trimester prediction of pre-eclampsia: external validity of algorithms in a prospectively enrolled cohort","volume":"44","author":"Oliveira","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"R48","doi-asserted-by":"publisher","first-page":"650.e1","DOI":"10.1016\/j.ajog.2019.09.041","article-title":"Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population","volume":"221","author":"Chaemsaithong","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"R49","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/uog.18816","article-title":"ASPRE trial: performance of screening for preterm pre-eclampsia","volume":"50","author":"Rolnik","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R50","unstructured":"Hypertension in pregnancy guideline. Society of Obstetric Medicine Australia and New Zealand. 2023. URL: https:\/\/www.somanz.org\/content\/uploads\/2023\/06\/SOMANZ_Hypertension_in_Pregnancy_Guideline_2023_Updated_30.6.23.pdf [Accessed 14-08-2026]"},{"key":"R51","unstructured":"Early pregnancy screening and prevention of preterm preeclampsia and related complications (C-Obs 61). RANZCOG. 2024. URL: https:\/\/ranzcog.edu.au\/wp-content\/uploads\/Screening-Prevention-Preterm-PET.pdf [Accessed 14-08-2026]"},{"issue":"Suppl 1","key":"R52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre\u2010eclampsia: a pragmatic guide for first\u2010trimester screening and prevention","volume":"145 Suppl 1","author":"Poon","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"R53","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/uog.22193","article-title":"Cost-effectiveness analysis of a model of first-trimester prediction and prevention of preterm pre-eclampsia compared with usual care","volume":"58","author":"Park","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"R54","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/uog.19111","article-title":"Screening for pre-eclampsia at 35-37\u2009weeks\u2019 gestation","volume":"52","author":"Panaitescu","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9694","key":"R55","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0140-6736(09)60736-4","article-title":"Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks\u2019 gestation (HYPITAT): a multicentre, open-label randomised controlled trial","volume":"374","author":"Koopmans","journal-title":"Lancet"},{"issue":"6","key":"R56","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa1800566","article-title":"Labor induction versus expectant management in low-risk nulliparous women","volume":"379","author":"Grobman","journal-title":"N Engl J Med"},{"issue":"2","key":"R57","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00404-023-07044-2","article-title":"Uterine arteries pulsatility index by Doppler ultrasound in the prediction of preeclampsia: an updated systematic review and meta-analysis","volume":"309","author":"Liu","journal-title":"Arch Gynecol Obstet"},{"key":"R58","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/679730","article-title":"First-trimester uterine artery Doppler analysis in the prediction of later pregnancy complications","volume":"2015","author":"Khong","journal-title":"Dis Markers"},{"issue":"4","key":"R59","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/uog.13338","article-title":"First-trimester maternal ophthalmic artery Doppler analysis for prediction of pre-eclampsia","volume":"44","author":"Gurgel Alves","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"8","key":"R60","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/aogs.12145","article-title":"Augmentation index and pulse wave velocity in normotensive and pre-eclamptic pregnancies","volume":"92","author":"Franz","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"8","key":"R61","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-046161","article-title":"Mean arterial pressure for predicting preeclampsia in Asian women: a longitudinal cohort study","volume":"11","author":"Zhu","journal-title":"BMJ Open"},{"issue":"17","key":"R62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20174246","article-title":"Preeclampsia: maternal systemic vascular disorder caused by generalized endothelial dysfunction due to placental antiangiogenic factors","volume":"20","author":"Tomimatsu","journal-title":"Int J Mol Sci"},{"issue":"3","key":"R63","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/uog.14799","article-title":"Implementation of the sFlt-1\/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice","volume":"45","author":"Stepan","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"12","key":"R64","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.3109\/14767050902994838","article-title":"A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic\/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study","volume":"22","author":"Chaiworapongsa","journal-title":"J Matern Fetal Neonatal Med"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:17:11Z","timestamp":1787663831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e95231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":64,"URL":"https:\/\/doi.org\/10.2196\/95231","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"v15iSuppl 3e95231"}}